Phage therapy: The Escherichia coli experience

Microbiology

Volumn 151, Issue 7, 2005, Pages 2133-2140

  Brüssow, Harald ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; PLACEBO;

ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL TRIAL; COLIPHAGE; DIARRHEA; DRUG EFFICACY; DRUG EXCRETION; DRUG SAFETY; DYSENTERY; ESCHERICHIA COLI; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; LIVER INJURY; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHIGELLA; TARGET CELL; TREATMENT FAILURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; BIOLOGICAL THERAPY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS;

ANIMALIA; ESCHERICHIA COLI;

EID: 22144437327     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.27849-0     Document Type: Review

References (84)

1. Abedon, S. T., Hyman, P. & Thomas, C. (2003). Experimental examination of bacteriophage latent-period evolution as a response to bacterial availability. Appl Environ Microbiol 69, 7499-7506.
2. Ackermann, H. W. & Krisch, H. M. (1997). A catalogue of T4-type bacteriophages. Arch Virol 142, 2329-2345.
3. Ackermann, H. W. & Nguyen, T. M. (1983). Sewage coliphages studied by electron microscopy. Appl Environ Microbiol 45, 1049-1059.
4. Albert M. J., Faruque, S. M., Faruque, A. S., Neogi, P. K., Ansaruzzaman, M., Bhuiyan, N. A., Alam, K. & Akbar, M. S. (1995). Controlled study of Escherichia coli diarrheal infections in Bangladeshi children. J Clin Microbiol 33, 973-977.
5. Alisky, J., Iczkowski, K., Rapoport, A. & Troitsky, N. (1998). Bacteriophages show promise as antimicrobial agents. J Infect 36, 5-15.
6. Babalova, E. G., Katsitadze, K. T., Sakvaredidze, L. A. & 10 other authors (1968). Preventive value of dried dysentery bacteriophage. Zh Mikrobiol Epidemiol Immunobiol 2, 143-145.
7. Barondess, J. J. & Beckwith, J. (1990). A bacterial virulence determinant encoded by lysogenic coliphage lambda. Nature 346, 871-874.
8. Barrow, P., Lovell, M. & Berchieri, A., Jr (1998). Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin Diagn Lab Immunol 5, 294-298.
9. Bhan, M. K., Mahalanabis, D., Fontaine, O. & Pierce, N. F. (1994). Clinical trials of improved oral rehydration salt formulations: a review. Bull World Health Organ 72, 945-955.
10. Black, R. E. (1990). Epidemiology of travelers' diarrhea and relative importance of various pathogens. Rev Infect Dis 12, S73-S79.
11. Bohannan, B. J. M. & Lenski, R. E. (2000). Linking genetic change to community evolution: insights from studies of bacteria and bacteriophage. Ecol Lett 3, 362-377.
12. Boyd, E. F. & Brüssow, H. (2002). Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved. Trends Microbiol 10, 521-529.
13. Brüssow, H., Fremont, M., Bruttin, A., Sidoti, J., Constable, A. & Fryder, V. (1994). Detection and classification of Streptococcus thermophilus bacteriophages isolated from industrial milk fermentation. Appl Environ Microbiol 60, 4537-4543.
14. Brüssow, H., Canchaya, C. & Hardt, W. D. (2004). Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68, 560-602.
15. Bruttin, A. & Brüssow, H. (2005). Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 49 (in press).
16. Buckling, A. & Rainey, P. B. (2002). Antagonistic coevolution between a bacterium and a bacteriophage. Proc R Soc Lond B 269, 931-936.
17. Bull, J. J., Levin, B. R., DeRouin, T., Walker, N. & Bloch, C. A. (2002). Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol 2, 35.
18. Canchaya, C., Proux, C., Fournous, G., Bruttin, A. & Brüssow, H. (2003). Prophage genomics. Microbiol Mol Biol Rev 67, 238-276.
19. Chang, D. E., Smalley, D. J., Tucker, D. L. & 8 other authors (2004). Carbon nutrition of Escherichia coli in the mouse intestine. Proc Natl Acad Sci U S A 101, 7427-7432.
20. Chibani-Chennoufi, S., Bruttin, A., Dillmann, M. L. & Brüssow, H. (2004a). Phage-host interaction: an ecological perspective. J Bacteriol 186, 3677-3686.
21. Chibani-Chennoufi, S., Canchaya, C., Bruttin, A. & Brüssow, H. (2004b). Comparative genomics of the T4-like Escherichia coli phage JS98: implications for the evolution of T4 phages. J Bacteriol 186, 8276-8286.
22. Chibani-Chennoufi, S., Dillmann, M. L., Marvin-Guy, L., Rami-Shojaei, S. & Brüssow, H. (2004c). Lactobacillus plantarum bacteriophage LP65: a new member of the SPO1-like genus of the family Myoviridae. J Bacteriol 186, 7069-7083.
23. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Dillmann, M.-L., Kutter, E., Qadri, F., Sarker, S. A. & Brüssow, H. (2004d). Isolation of Escherichia coli bateriophages from the stool of pediatric diarrhea patients in Bangladesh. J Bacteriol 186, 8287-8294.
24. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S. & Brüssow, H. (2004e). In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob Agents Chemother 48, 2558-2569.
25. Dhillon, T. S., Dhillon, E. K., Chau, H. C., Li, W. K. & Tsang, A. H. (1976). Studies on bacteriophage distribution: virulent and temperate bacteriophage content of mammalian feces. Appl Environ Microbiol 32, 68-74.
26. Donnenberg, M. S. (2002). Escherichia coli: Virulence Mechanisms of a Versatile Pathogen. Amsterdam: Academic Press.
27. Dubos, R. J., Hookey Straus, J. & Pierce, C. (1943). The multiplication of bacteriophage in vivo and its protective effect against an experimental infection with Shigella dysenteriae. J Exp Med 78, 161-168.
28. Duckworth, D. H. (1999). History of virology: bacteriophages. In Encyclopedia of Virology, pp. 725-730. Edited by A. Granoff & R. G. Webster. Memphis, TN: Academic Press.
29. Furuse, K. (1987). Distribution of coliphages in the general environment: general considerations. In Phage Ecology, pp. 87-124. Edited by S. M. Goyal, C. P. Gerba & G. Bitton. New York: Wiley.
30. Furuse, K., Osawa, S., Kawashiro, J., Tanaka R., Ozawa, A., Sawamura, S., Yanagawa, Y., Nagao, T. & Watanabe, I. (1983). Bacteriophage distribution in human faeces: continuous survey of healthy subjects and patients with internal and leukaemic diseases. J Gen Virol 64, 2039-2043.
31. Geier, M. R. & Merril, C. R. (1972). Lambda phage transcription in human fibroblasts. Virology 47, 638-643.
32. Goode, D., Allen, V. M. & Barrow, P. A. (2003). Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Appl Environ Microbiol 69, 5032-5036.
33. Goodridge, L., Gallaccio, A. & Griffiths, M. W. (2003). Morphological, host range, and genetic characterization of two coliphages. Appl Environ Microbiol 69, 5364-5371.
34. Hadas, H., Einav, M., Fishov, I. & Zaritsky, A. (1997). Bacteriophage T4 development depends on the physiology of its host Escherichia coli. Microbiology 143, 179-185.
35. Harcombe, W. R. & Bull, J. J. (2005). Phage impact in two-species bacterial communities. Appl Environ Microbiol (in press).
36. Häusler, T. (2003). Gesund durch Viren. München: Piper Verlag (in German).
37. Huff, W. E., Huff, G. R., Rath, N. C., Balog, J. M. & Donoghue, A. M. (2002). Prevention of Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray. Poult Sci 81, 1486-1491.
38. Kamp, D., Kahmann, R., Zipser, D., Broker, T. R. & Chow, L. T. (1978). Inversion of the G DNA segment of phage Mu controls phage infectivity. Nature 271, 577-580.
39. Karam, J. D. (1994). Molecular Biology of Bacteriophage T4. Washington, DC: American Society for Microbiology.
40. Kasman, L. M., Kasman, A., Westwater, C., Dolan, J., Schmidt, M. G. & Norris, J. S. (2002). Overcoming the phage replication threshold: a mathematical model with implications for phage therapy. J Virol 76, 5557-5564.
41. Krogfelt, K. A., Poulsen, L. K. & Molin, S. (1993). Identification of coccoid Escherichia coli BJ4 cells in the large intestine of streptomycin-treated mice. Infect Immun 61, 5029-5034.
42. Kudva, I. T., Jelacic, S., Tarr, P. I., Youderian, P. & Hovde, C. J. (1999). Biocontrol of Escherichia coli O157 with O157-specific bacteriophages. Appl Environ Microbiol 65, 3767-3773.
43. Kutter, E., Kellenberger, E., Carlson, K., Eddy, S., Neitzel, J., Messinger, L., North, J. & Guttman, B. (1994). Effects of bacterial growth conditions and physiology on T4 infection. In Molecular Biology of Bacteriophage T4, pp. 406-418. Edited by J. D. Karam. Washington, DC: American Society for Microbiology
44. Levin, B. R. & Bull, J. J. (2004). Population and evolutionary dynamics of phage therapy. Nat Rev Microbiol 2, 166-173.
45. Lu, Z., Breidt, F., Jr, Fleming, H. P., Altermann, E. & Klaenhammer, T. R. (2003a). Isolation and characterization of a Lactobacillus plantarum bacteriophage, phiJL-1, from a cucumber fermentation. Int J Food Microbiol 84, 225-235.
46. Lu, Z., Breidt, F., Plengvidhya, V. & Fleming, H. P. (2003b). Bacteriophage ecology in commercial sauerkraut fermentations. Appl Environ Microbiol 69, 3192-3202.
47. Luria, S. E. & Delbrück, M. (1943). Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28, 491-511.
48. Merril, C. R., Geier, M. R. & Petricciani, J. C. (1971). Bacterial virus gene expression in human cells. Nature 233, 398-400.
49. Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S. & Adhya, S. (1996). Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A 93, 3188-3192.
50. Merril, C. R., Scholl, D. & Adhya, S. L. (2003). The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov 2, 489-497.
51. Miller, E. S., Kutter, E., Mosig, G., Arisaka, F., Kunisawa, T. & Ruger, W. (2003). Bacteriophage T4 genome. Microbiol Mol Biol Rev 67, 86-156.
52. Mizoguchi, K., Morita, M., Fischer, C. R., Yoichi, M., Tanji, Y. & Unno, H. (2003). Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. Appl Environ Microbiol 69, 170-176.
53. Morita, M., Tanji, Y., Mizoguchi, K., Akitsu, T., Kijima, N. & Unno, H. (2002). Characterization of a virulent bacteriophage specific for Escherichia coli O157:H7 and analysis of its cellular receptor and two tail fiber genes. FEMS Microbiol Lett 211, 77-83.
54. Morton, H. E. & Engley, F. B. J. (1945). The protective action of dysentery bacteriophage in experimental infections in mice. J Bacteriol 49, 245-255.
55. Morton, H. E. & Perez-Otero, J. E. (1945). The increase of bacteriophage in vivo during experimental infections with Shigella paradysenteriae, flexner, in mice. J Bacteriol 49, 237-244.
56. O'Flynn, G., Ross, R. P., Fitzgerald, G. F. & Coffey, A. (2004). Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl Environ Microbiol 70, 3417-3424.
57. Payne, R. J. & Jansen, V. A. (2003). Pharmacokinetic principles of bacteriophage therapy. Clin Pharmacokinet 42, 315-325.
58. Poulsen, L. K., Licht, T. R., Rang, C., Krogfelt, K. A. & Molin, S. (1995). Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice. J Bacteriol 177, 5840-5845.
59. Repoila, F., Tétart, F., Bouet, J. Y. & Krisch, H. M. (1994). Genomic polymorphism in the T-even bacteriophages. EMBO J 13, 4181-4192.
60. Robins-Browne, R. M. (1987). Traditional enteropathogenic Escherichia coli of infantile diarrhea. Rev Infect Dis 9, 28-53.
61. Savarino, S. J., Hall, E. R., Bassily, S. & 14 other authors (2002). Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants. Pediatr Infect Dis J 21, 322-330.
62. Schade, A. L. & Caroline, L. (1943). The preparation of a polyvalent dysentery bacteriophage in a dry and stable form. I. Preliminary investigations and general procedures. J Bacteriol 46, 463-473.
63. Schade, A. L. & Caroline, L. (1944a). The preparation of a polyvalent dysentery bacteriophage in a dry and stable form. II. Factors affecting the stabilization of dysentery bacteriophage during lyophilization. J Bacteriol 48, 179-190.
64. Schade, A. L. & Caroline, L. (1944b). The preparation of a polyvalent dysentery bacteriophage in a dry and stable form. III. Stability of the dried bacteriophage towards heat, humidity, age and acidity. J Bacteriol 48, 243-251.
65. Schluederberg, S. A., Marshall, B., Tachibana, C. & Levy, S. B. (1980). Recovery frequency of phages lambda and M13 from human and animal faeces. Nature 283, 792-794.
66. Scholl, D., Rogers, S., Adhya, S. & Merril, C. R. (2001). Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli. J Virol 75, 2509-2515.
67. Schubbert, R., Renz, D., Schmitz, B. & Doerfler, W. (1997). Foreign (M13) DNA ingested by mice reaches peripheral leukocytes, spleen, and liver via the intestinal wall mucosa and can be covalently linked to mouse DNA. Proc Natl Acad Sci U S A 94, 961-966.
68. Schubbert, R., Hohlweg, U., Renz, D. & Doerfler, W. (1998). On the fate of orally ingested foreign DNA in mice: chromosomal association and placental transmission to the fetus. Mol Gen Genet 259, 569-576.
69. Slopek, S., Weber-Dabrowska, M., Dabrowski, M. & Kucharewicz-Krukowska, A. (1987). Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch Immunol Ther Exp 35, 569-583.
70. Smith, H. W. & Huggins, M. B. (1982). Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 128, 307-318.
71. Smith, H. W. & Huggins, M. B. (1983). Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol 129, 2659-2675.
72. Smith, H. W., Huggins, M. B. & Shaw, K. M. (1987a). Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J Gen Microbiol 133, 1127-1135.
73. Smith, H. W., Huggins, M. B. & Shaw, K. M. (1987b). The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 133, 1111-1126.
74. Snyder, J. D. & Merson, M. H. (1982). The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. Bull World Health Organ 60, 605-613.
75. Sulakvelidze, A. & Kutter, E. (2005). Bacteriophage therapy in humans. In Bacteriophages - Biology and Applications, pp. 381-436. Edited by E. Kutter & A. Sulakvelidze. Boca Raton, FL: CRC Press.
76. Sulakvelidze, A., Alavidze, Z. & Morris, J. G., Jr (2001). Bacteriophage therapy. Antimicrob Agents Chemother 45, 649-659.
77. Summers, W. C. (1999). Félix d'Hérelle and the Origins of Molecular Biology. New Haven, CT: Yale University Press.
78. Summers, W. C. (2001). Bacteriophage therapy. Annu Rev Microbiol 55, 437-451.
79. Tétart, F., Desplats, C. & Krisch, H. M. (1998). Genome plasticity in the distal tail fiber locus of the T-even bacteriophage: recombination between conserved motifs swaps adhesin specificity. J Mol Biol 282, 543-556.
80. Wagner, P. L. & Waldor, M. K. (2002). Bacteriophage control of bacterial virulence. Infect Immun 70, 3985-3993.
81. Weld, R. J., Butts, C. & Heinemann, J. A. (2004). Models of phage growth and their applicability to phage therapy. J Theor Biol 227, 1-11.
82. Wiggins, B. A. & Alexander, M. (1985). Minimum bacterial density for bacteriophage replication: implications for significance of bacteriophages in natural ecosystems. Appl Environ Microbiol 49, 19-23.
83. Wommack, K. E. & Colwell, R. R. (2000). Virioplankton: viruses in aquatic ecosystems. Microbiol Mol Biol Rev 64, 69-114.
84. You, L., Suthers, P. F. & Yin, J. (2002). Effects of Escherichia coli physiology on growth of phage T7 in vivo and in silico. J Bacteriol 184, 1888-1894.